Cardiac Tamponade During Uninterrupted Oral Anticoagulant Therapy for Catheter Ablation for Atrial Fibrillation

JACC Clin Electrophysiol. 2020 Jul;6(7):796-798. doi: 10.1016/j.jacep.2020.03.002.

Authors

John W Eikelboom¹, Alexander P Benz²

Affiliations

¹ Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada. Electronic address: eikelbj@mcmaster.ca.
² Population Health Research Institute, Hamilton Health Sciences and McMaster University, Hamilton, Ontario, Canada.

PMID: 32703561
DOI: 10.1016/j.jacep.2020.03.002

No abstract available

Keywords: DOAC; VKA; atrial fibrillation; cardiac tamponade; catheter ablation.

Publication types

Editorial
Comment

MeSH terms

Anticoagulants / adverse effects
Atrial Fibrillation* / drug therapy
Atrial Fibrillation* / surgery
Cardiac Tamponade* / etiology
Catheter Ablation*
Humans
Warfarin / adverse effects

Substances

Anticoagulants
Warfarin